These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
707 related articles for article (PubMed ID: 32424039)
1. The emerging role of α-synuclein truncation in aggregation and disease. Sorrentino ZA; Giasson BI J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039 [TBL] [Abstract][Full Text] [Related]
2. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions. Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435 [TBL] [Abstract][Full Text] [Related]
3. Carboxy-terminal truncations of mouse α-synuclein alter aggregation and prion-like seeding. Sorrentino ZA; Xia Y; Gorion KM; Hass E; Giasson BI FEBS Lett; 2020 Apr; 594(8):1271-1283. PubMed ID: 31912891 [TBL] [Abstract][Full Text] [Related]
4. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy. Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157 [TBL] [Abstract][Full Text] [Related]
5. Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies. Hass EW; Sorrentino ZA; Xia Y; Lloyd GM; Trojanowski JQ; Prokop S; Giasson BI Acta Neuropathol Commun; 2021 Aug; 9(1):146. PubMed ID: 34454615 [TBL] [Abstract][Full Text] [Related]
6. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model. Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679 [TBL] [Abstract][Full Text] [Related]
7. The effect of truncation on prion-like properties of α-synuclein. Terada M; Suzuki G; Nonaka T; Kametani F; Tamaoka A; Hasegawa M J Biol Chem; 2018 Sep; 293(36):13910-13920. PubMed ID: 30030380 [TBL] [Abstract][Full Text] [Related]
8. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
9. alpha-Synucleinopathy models and human neuropathology: similarities and differences. Kahle PJ Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682 [TBL] [Abstract][Full Text] [Related]
10. Is Multiple System Atrophy a Prion-like Disorder? Jellinger KA; Wenning GK; Stefanova N Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255 [TBL] [Abstract][Full Text] [Related]
11. Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression. Sorrentino ZA; Goodwin MS; Riffe CJ; Dhillon JS; Xia Y; Gorion KM; Vijayaraghavan N; McFarland KN; Golbe LI; Yachnis AT; Giasson BI Acta Neuropathol Commun; 2019 Sep; 7(1):142. PubMed ID: 31477175 [TBL] [Abstract][Full Text] [Related]
12. A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models. Lloyd GM; Quintin S; Sorrentino ZA; Gorion KM; Bell BM; Long B; Paterno G; Giasson BI Acta Neuropathol Commun; 2024 Jun; 12(1):91. PubMed ID: 38858742 [TBL] [Abstract][Full Text] [Related]
13. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils. Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice. Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358 [TBL] [Abstract][Full Text] [Related]
15. Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice. Lloyd GM; Sorrentino ZA; Quintin S; Gorion KM; Bell BM; Paterno G; Long B; Prokop S; Giasson BI Acta Neuropathol; 2022 Jun; 143(6):663-685. PubMed ID: 35488930 [TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies. Graves NJ; Gambin Y; Sierecki E Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510 [TBL] [Abstract][Full Text] [Related]
17. Truncation or proteolysis of α-synuclein in Parkinsonism. Suthar SK; Lee SY Ageing Res Rev; 2023 Sep; 90():101978. PubMed ID: 37286088 [TBL] [Abstract][Full Text] [Related]
18. The Role of α-Synuclein in Etiology of Neurodegenerative Diseases. Krawczuk D; Groblewska M; Mroczko J; Winkel I; Mroczko B Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273146 [TBL] [Abstract][Full Text] [Related]
19. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies. Peng C; Gathagan RJ; Lee VM Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258 [TBL] [Abstract][Full Text] [Related]
20. Propagation of pathological α-synuclein in marmoset brain. Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]